Sonde Health raises $16 million Series A for vocal diagnostics

Sonde Health, which is developing a voice-based diagnostics platform, has secured $16 million in a Series A financing round led by M Ventures, with MP Healthcare Venture Management, Neoteny 4, LP, Canepa Healthcare, and founder PureTech Health.

The company's technology enables devices such as smartphones and smart speakers to provide screening  for psychological and physical disease through acoustic analysis of snippets of voice. It works by sensing and analyzing subtle changes in the voice to create a range of persistent brain, muscle, and respiratory health measurements. This approach may enable the prevention and treatment of conditions ranging from depression and respiratory diseases to chronic diseases of aging. So far, Sonde has collected voice and health data from over 10,000 subjects as part of the ongoing validation of its platform.

"Our longstanding vision has been to harness the health information present in billions of daily voice interactions to create a 21st century thermometer, or ‘vocometer’, that provides broad digital healthcare decision support needed to enable new models of precision and preventative medicine," said Jim Harper, co-founder and chief operating officer of Sonde Health.

Sonde intends to use the proceeds from the financing to expand its capability across multiple health conditions and device types and to fund commercialization activities.